Professional article
Open access

The role of immunosuppression in the transplantation of allogenic neural precursors derived from human pluripotent stem cells for Parkinson's disease

Published inStem cell research & therapy, vol. S6, no. 006
Publication date2013

Objective: Neural progenitor cells (NPC) derived from human embryonic stem cells have the potential to differentiate into mature neurons after transplantation in the brain, opening the possibility of regenerative cell therapy for neurodegenerative disorders like Parkinson's disease. For such therapy, the source of NPC is genetically unrelated to the patient, leading to potential rejection of the transplanted cells by the host's immune response. Rejection can be prevented by the use of immunosuppressive drugs (ISD). Previous works have suggested that cyclosporine and dexamethasone used in classical immunosuppressive regimen could prevent the terminal differentiation of NPC into mature neurons depending on culture conditions. Methods: We have investigated in vitro the role of other ISD, Intra venous Immunoglobulins (IvIG), mycophenolate mofetil and tacrolimus. We have tested the immunosuppressive activity of tacrolimus and cyclosporine on the effector of natural killer (NK) and CD8+T-cells and performed a microarray to analyse the difference between the two drugs for the neuron differentiation. Finally, human transplanted neuroprecursor cell survival has been analyzed in rats treated with tacrolimus or cyclosporine and anti-inflammatory treatments. Results: IvIG and mycophenolate mofetil interfere with the development of NPC into mature neurons, but tacrolimus do not inhibit the maturation process of NPC. Microarray experiments demonstrate significant differences between cyclosporine and tacrolimus gene expression during NPC maturation into mature neurons. Tacrolimus like cyclosporine is able to inhibit the CD8+T-cells activation against neural progenitors, but both are unable to block NK cells activity. NK cells could be potential harmful weapons to reject NPC and mature neurons. In rats treated with both immunosuppressive (tacrolimus or cyclosporine) and anti-inflammatory treatments, engrafted human neuroprecursors cell survival is good and the microglial density is low. Conclusion: These data suggest in vivo that both tacrolimus and cyclosporine, with an anti-inflammatory treatment like prednisolone, promote graft survival and minimise the host microglial response.

  • Human pluripotent stem cells
  • Neuron precursor cells
  • NK cells
  • T cells
  • Tacrolimus
  • Cyclosporine
  • Prednisolone
  • Immunosuppression
  • Parkinson's disease
Citation (ISO format)
DE RHAM, Casimir et al. The role of immunosuppression in the transplantation of allogenic neural precursors derived from human pluripotent stem cells for Parkinson’s disease. In: Stem cell research & therapy, 2013, vol. S6, n° 006. doi: 10.4172/2157-7633.S6-006
Main files (1)
Article (Published version)
ISSN of the journal1757-6512

Technical informations

Creation07/21/2014 1:32:00 PM
First validation07/21/2014 1:32:00 PM
Update time03/14/2023 9:45:58 PM
Status update03/14/2023 9:45:58 PM
Last indexation05/02/2024 3:33:04 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack